M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells
- PMID: 31006094
- DOI: 10.1007/s11033-019-04799-3
M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells
Abstract
Colorectal cancer (CRC) is the third most common cancer in both men and women. Oncolytic viral-based therapy methods seem to be promising for CRC treatment. Vesicular stomatitis virus (VSV) is considered as a potent candidate in viral therapy for several tumors. VSV particles with mutated matrix (M) protein are capable of initiating cell death cascades while not being harmful to the immune system. In the current study, the effects of the VSV M-protein was investigated on the apoptosis of the colorectal cancer SW480 cell. Wild-type, M51R, and ΔM51 mutants VSV M-protein genes were cloned into the PCDNA3.1 vector and transfected into the SW480 cells. The results of the MTT assay, Western blotting, and Caspase 3, 8, and 9 measurement, illustrated that both wild and M51R mutant M-proteins can destroy the SW480 colorectal cancer cells. DAPI/TUNEL double-staining reconfirmed the apoptotic effects of the M-protein expression. The ΔM51 mutant M-protein is effective likewise M51R, somehow it can be considered as a safer substitution.
Keywords: Apoptosis; Colon cancer; Oncolytic virus; VSV.
Similar articles
-
Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo.J Virol. 2011 Jun;85(12):5708-17. doi: 10.1128/JVI.02393-10. Epub 2011 Mar 30. J Virol. 2011. PMID: 21450822 Free PMC article.
-
Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.J Surg Res. 2020 Jan;245:127-135. doi: 10.1016/j.jss.2019.07.032. Epub 2019 Aug 12. J Surg Res. 2020. PMID: 31415934
-
Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.Virology. 2007 Jan 5;357(1):41-53. doi: 10.1016/j.virol.2006.07.022. Epub 2006 Sep 7. Virology. 2007. PMID: 16962155
-
Vesicular stomatitis virus: re-inventing the bullet.Trends Mol Med. 2004 May;10(5):210-6. doi: 10.1016/j.molmed.2004.03.003. Trends Mol Med. 2004. PMID: 15121047 Review.
-
[Vesicular stomatitis virus in the fight against cancer].Med Sci (Paris). 2013 Feb;29(2):175-82. doi: 10.1051/medsci/2013292015. Epub 2013 Feb 28. Med Sci (Paris). 2013. PMID: 23452604 Review. French.
Cited by
-
Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions.Cancers (Basel). 2025 May 31;17(11):1854. doi: 10.3390/cancers17111854. Cancers (Basel). 2025. PMID: 40507337 Free PMC article. Review.
-
The power of mumps virus: Matrix protein activates apoptotic pathways in human colorectal cell lines.PLoS One. 2023 Dec 13;18(12):e0295819. doi: 10.1371/journal.pone.0295819. eCollection 2023. PLoS One. 2023. PMID: 38091318 Free PMC article.
-
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.J Exp Clin Cancer Res. 2023 Oct 27;42(1):284. doi: 10.1186/s13046-023-02848-1. J Exp Clin Cancer Res. 2023. PMID: 37891570 Free PMC article.
-
NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein.Mol Ther Oncolytics. 2021 Nov 24;23:593-601. doi: 10.1016/j.omto.2021.11.013. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34977336 Free PMC article.
-
Cancer-Specific Activation of the Vesicular Stomatitis Virus Matrix by Survivin Promoter in Breast Cancer Cells.Mol Biotechnol. 2025 Jan 17. doi: 10.1007/s12033-024-01359-4. Online ahead of print. Mol Biotechnol. 2025. PMID: 39820852
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials